A low mean arterial pressure (MAP) or cardiac index (CI) is common after cardiac surgery
1,
2
and typically triggers treatment with fluid bolus therapy (FBT).
3,
4
However, insufficient FBT may fail to correct such instability, while excessive FBT may contribute to pulmonary congestion. Therefore, defining the optimal approach to FBT after cardiac surgery is clinically relevant.
5,
6
Fischer GW, Levin MA. Vasoplegia during cardiac surgery: current concepts and management. Semin Thorac Cardiovasc Surg 2010; 22: 140-4
Carrel T, Englberger L, Mohacsi P, et al. Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance. J Card Surg 2000; 15: 347-53
Parke RL, McGuinness SP, Gilder E, McCarthy LW. Intravenous fluid use after cardiac surgery: a multicentre, prospective, observational study. Crit Care Resusc 2014; 16: 164-9
Cecconi M, De Backer D, Antonelli M, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med 2014; 40: 1795-815
Teixeira C, Garzotto F, Piccinni P, et al. Fluid balance and urine volume are independent predictors of mortality in acute kidney injury. Crit Care 2013; 17: R14
Garzotto F, Ostermann M, Martín-Langerwerf D, et al. The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients. Crit Care 2016; 20: 196
During haemodynamic instability, FBT is often administered rapidly. However, it may be better to administer the same amount of fluid as a smaller very rapid (3–4 minutes) bolus followed by a continuous infusion of the remaining fluid. This is because rapid FBT increases plasma atrial natriuretic peptide levels, an effect associated with glycocalyx injury, greater fluid extravasation, and intestinal oedema. 7
Chappell D, Bruegger D, Potzel J, et al. Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx. Crit Care 2014; 18: 538
Bark BP and Grande PO. Infusion rate and plasma volume expansion of dextran and albumin in the septic guinea pig. Acta Anaesthesiol Scand 2014; 58: 44-51
Bark BP, Persson J, Grände PO. Importance of the infusion rate for the plasma expanding effect of 5% albumin, 6% HES 130/0.4, 4% gelatin, and 0.9% NaCl in the septic rat. Crit Care Med 2013; 41: 857-66
Slower 4% albumin infusion could achieve more sustained haemodynamic changes after cardiac surgery, but it may fail to correct hypotension or low cardiac output rapidly enough. Logically, a small but very rapid fluid bolus followed by continuous infusion may combine the advantage of a rapid response with those associated with a sustained effect. Despite these physiological considerations and the findings of an international survey that about 30% of intensive care unit (ICU) clinicians define FBT as fluid given in less than 10 minutes while 50% define it as given over 30 minutes, 10
Glassford NJ, Mårtensson J, Eastwood GM, et al. Defining the characteristics and expectations of fluid bolus therapy: a worldwide perspective. J Crit Care 2016; 35: 126-32
Accordingly, we conducted a prospective before-and-after study of the haemodynamic effect of a rapid complete bolus of 4% albumin compared with a rapid small bolus of 4% albumin followed by a slower continuous infusion over 30 minutes (combined FBT) in post-cardiac surgery patients. We hypothesised that the combined FBT approach would achieve greater MAP effects than rapid FBT during a 30-minute post-FBT observation period.
Methods
We prospectively obtained institutional ethics approval for this study (Reference No. LNR/16/Austin/358). Individual consent was waived, as giving FBT within 30 minutes is common practice in Australia and New Zealand and in our ICU.
10
Glassford NJ, Mårtensson J, Eastwood GM, et al. Defining the characteristics and expectations of fluid bolus therapy: a worldwide perspective. J Crit Care 2016; 35: 126-32
Study design
Within an overarching quality improvement program evaluating FBT after cardiac surgery, this single-centre prospective before-and-after study was conducted in a university-affiliated tertiary teaching hospital in Melbourne, Australia, between July 2017 and January 2020.
As with a previous study, 11
Yanase F, Bitker L, Lucchetta L, et al. Comparison of the hemodynamic and temperature effects of a 500 mL bolus of 4% albumin at room versus body temperature in cardiac surgery patients. J Cardiothorac Vasc Anesth 2021; 35: 499-507
We excluded pregnant women and patients receiving intra-aortic balloon counterpulsation or extracorporeal membrane oxygenation. Patients were also excluded if any major confounding interventions, which could affect haemodynamic parameters, became necessary during the study period (Online Appendix, supplementary appendix 1).
Fluid bolus therapy
The clinicians prescribed 4% albumin FBT based on their clinical judgements. As a part of their FBT quality improvement program, they introduced small bolus FBT followed by continuous infusion (combined FBT). The albumin was stored and given at room temperature. We allocated the first 25 patients to the rapid FBT group and the second 25 patients to the combined FBT group. In the rapid FBT group, 500 mL of albumin was infused rapidly (within 15 minutes) through a central line using a hand pump as previously reported.11 In the combined FBT group, a small 4% albumin bolus (200 mL) was given rapidly (within 10 minutes) through a central line, and a continuous infusion (300 mL albumin) was given over 30 minutes (Online Appendix, supplementary figure 1).
Data collection
We collected haemodynamic data, including systolic arterial pressure, diastolic arterial pressure, MAP, central venous pressure (CVP), systolic pulmonary arterial pressure (PAP), diastolic PAP, mean PAP, heart rate, CI and peripheral oxygen saturation (SpO2) on a second-by-second basis using the MediCollector logging software (MediCollector, Boston, MA, USA). We measured CI continuously or intermittently according to the pulmonary artery catheter using the thermodilution technique.
In the rapid FBT group, CI was measured at four time points: before FBT, immediately (0 minutes) after FBT, 15 minutes after FBT, and 30 minutes after FBT. In the combined FBT group, CI was measured immediately after the small fluid bolus, 15 minutes after small fluid bolus, and 30 minutes after the 200 mL FBT. We recorded baseline haemodynamic parameters for a minimum of 3 minutes before the 500 mL FBT or the 200 mL FBT. Ventilator setting and all drug infusions (catecholamine and sedative drugs) at the time of inclusion were recorded and remained unchanged during the study period.
Finally, patients admitted to the ICU only during business hours were recruited because at least one trained researcher was needed to observe study patients and record all interventions, including minor confounders during the study periods. When patients needed unexpected interventions that met the exclusion criteria (Online Appendix, supplementary appendix 1), we stopped data collection and excluded such patients. However, when there were minor confounders (Online Appendix, supplementary appendix 2), we continued the recording and the data were included for analysis.